This inventor holds 1 USPTO granted patent. Top assignee: Medimmune Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Mark Terence Liddament: Innovator in Protein Variants
Introduction
Mark Terence Liddament is a notable inventor based in Granta Park, GB. He has made significant contributions to the field of biotechnology, particularly in the development of protein variants that have potential therapeutic applications. His work focuses on enhancing the activity and stability of CTLA-4 protein variants.
Latest Patents
Liddament holds a patent for CTLA-4 protein variants. These variants demonstrate increased activity compared to the wild-type in cell assays and exhibit enhanced stability. Such innovations are particularly useful for treating disorders where the attenuation of the T cell response is beneficial. He has 1 patent to his name.
Career Highlights
Liddament is currently associated with MedImmune Limited, a leading biotechnology company. His role involves research and development aimed at advancing therapeutic solutions in immunology. His expertise in protein engineering has positioned him as a key figure in his field.
Collaborations
Throughout his career, Liddament has collaborated with several esteemed colleagues, including Ruth Franks and Lutz Ulrich Jochen Wilhelm Jermutus. These collaborations have fostered innovation and contributed to the advancement of their shared research goals.
Conclusion
Mark Terence Liddament's work in developing CTLA-4 protein variants showcases his commitment to advancing biotechnology. His contributions have the potential to impact therapeutic strategies significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile